Page last updated: 2024-08-23

paclitaxel and macelignan

paclitaxel has been researched along with macelignan in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ha, I; Han, HK; Kang, KW; Lee, BJ; Qiang, F; Woo, ER	1
Baeyens, JM; Contreras-Cáceres, R; Leiva, MC; López-Romero, JM; Mayevych, I; Melguizo, C; Ortiz, R; Perazzoli, G; Prados, J; Sarabia, F	1

Other Studies

2 other study(ies) available for paclitaxel and macelignan

Article	Year
Effect of maceligan on the systemic exposure of paclitaxel: in vitro and in vivo evaluation. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2010, Oct-09, Volume: 41, Issue:2 Topics: Animals; Antineoplastic Agents, Phytogenic; Area Under Curve; Blotting, Western; Cytochrome P-450 CYP3A; Drug Evaluation, Preclinical; Half-Life; Humans; Lignans; Microsomes, Liver; Paclitaxel; Rats	2010
Tripalmitin nanoparticle formulations significantly enhance paclitaxel antitumor activity against breast and lung cancer cells in vitro. Scientific reports, 2017, 10-18, Volume: 7, Issue:1 Topics: Antineoplastic Agents; beta-Cyclodextrins; Breast Neoplasms; Cell Line; Female; Humans; Lignans; Lung Neoplasms; MCF-7 Cells; Nanoparticles; Neoplastic Stem Cells; Paclitaxel; Polyethylene Glycols; Spheroids, Cellular; Triglycerides; Tumor Cells, Cultured	2017

Article

Year

Effect of maceligan on the systemic exposure of paclitaxel: in vitro and in vivo evaluation.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2010, Oct-09, Volume: 41, Issue:2

Topics: Animals; Antineoplastic Agents, Phytogenic; Area Under Curve; Blotting, Western; Cytochrome P-450 CYP3A; Drug Evaluation, Preclinical; Half-Life; Humans; Lignans; Microsomes, Liver; Paclitaxel; Rats

2010

Tripalmitin nanoparticle formulations significantly enhance paclitaxel antitumor activity against breast and lung cancer cells in vitro.

Scientific reports, 2017, 10-18, Volume: 7, Issue:1

Topics: Antineoplastic Agents; beta-Cyclodextrins; Breast Neoplasms; Cell Line; Female; Humans; Lignans; Lung Neoplasms; MCF-7 Cells; Nanoparticles; Neoplastic Stem Cells; Paclitaxel; Polyethylene Glycols; Spheroids, Cellular; Triglycerides; Tumor Cells, Cultured

2017